ArticleArchives of Razi Institute2024
Investigating the Effect of eradication of
Article in Archives of Razi Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative molecular detection ofIranian journal of microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori is one of the most prevalent chronic infections globally. It is hypothesised that diabetes mellitus increases the incidence of Helicobacter pylori infection; however, the available data on the relationship between Helicobacter pylori and the level of blood sugar control (HbA1C) in diabetics are limited and contradictory. The present study therefore aims to investigate the impact of Helicobacter pylori infection on the blood sugar control of diabetic patients. In this experimental study, 61 type II diabetic patients with or without dyspepsia symptoms, in whom Helicobacter pylori infection was proven by anti-Helicobacter pylori IgG serological method, were treated with four anti-Helicobacter pylori drug regimens (bismuth+ metronidazole) +tetracycline + omeprazole. The HbAlC level was quantified prior to the commencement of Helicobacter pylori infection treatment and two months following the conclusion of the infection treatment, following the confirmation of Helicobacter pylori infection eradication through urea breath test and the calculation of the mean HbAlC levels before and after the infection treatment. The data were analysed using the Statistical Package for the Social Sciences (SPSS) software and a paired Student's t-test. The results indicated that the average age of the subjects was 52.4±10.4 years, with 39 males (63.9%) and 22 females (36.1%) comprising the sample. The mean duration of diabetes at the time of diagnosis for the subjects in the study was 8.7±5.5 years. The results of this study demonstrate that Helicobacter pylori infection was successfully eradicated in all patients, as evidenced by the urea breath test (UBT). The mean HbAlC level prior to treatment was 8.6±1.2, while the mean HbAlC level following treatment was 7.9±1.2. This represents a statistically significant change (P<0.05). It was concluded that a positive relationship exists between the eradication effect of Helicobacter pylori and blood sugar control (reduction of HbAlC). However, further studies in diabetic patients are recommended to obtain more accurate results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.